Werkgroep Cardiologische centra Nederland

ELIXA (Completed)

Evaluation of Cardiovascular Outcomes in Patients With Type 2 Diabetes After Acute Coronary Syndrome During Treatment With AVE0010 (Lixisenatide)
Medicine
lixisenatide
Population
Diabetes mellitus
Phase
III
Starting year
2010
More information
ClinicalTrials.gov

Director of Study

dr. J.H. Cornel (Cardioloog)
Alkmaar, Noordwest Ziekenhuisgroep

Publications: ELIXA

  • Discussant: the ELIXA trial results – What do  they mean?ESC 2015 - ELIXA - Diabetes mellitus
  • Evaluation of LIXisenatide in Acute Coronary Syndrome (ELIXA)ESC 2015 - ELIXA - Diabetes mellitus

Publications by WCN study

Publications WCN studies by WCN member